Darupakhsh Factories (DPAK) Lifts Six-Month Net Profit 7.2-Fold to 60,998 Billion Rials at a 66.1% Gross Margin
Sahmino Newsroom | 20 November 2026 | 17 hours ago
In its standalone income statement for the six months to 31 Shahrivar 1405 (22 September 2026), filed on Codal on 18 November 2026 (27 Aban), Darupakhsh Factories (DPAK) reported operating revenue of 131,605 billion rials, up 269% from 35,705 billion rials in the same period a year earlier (a restated comparative column). Gross profit rose from 16,537 to 86,994 billion rials and the gross margin from 46.3% to 66.1%.
Operating profit was 85,733 billion rials (up 460%) and net profit 60,998 billion rials, against 8,528 billion rials a year earlier. Earnings per share rose from 165 to 1,179 rials. That net profit equals 227% of the full fiscal 1404 profit (26,836 billion rials), and the six-month revenue equals 152% of that year's revenue (86,362 billion rials). Current-year income tax was 17,330 billion rials, finance costs 6,755 billion rials, and the company's capital is 51,800 billion rials.
In the Codal income statement the current-period column is headed as submitted to the auditor, although the Codal letter's title describes the statements as audited.
Sahmino context
What the prices have done since this story was published, and what Sahmino wrote around it
From Sahmino that week
Dividend payment: POYA
Calendar | 21 NovemberDividend payment: STIZ
Calendar | 21 NovemberThe PLSH Refinery Fund Still Trades 26% Below Its Net Asset Value, a Discount That Has Narrowed Since September (Friday 20 November 2026)
Article | 20 NovemberPrice, Not Tonnage: NALM Sold Less Aluminium Over Seven Months Yet More Than Doubled Its Sales (Thursday 19 November 2026)
Article | 19 November
More from this market
Daropakhsh Distribution (DPDZ) Lifts Six-Month Net Profit 256%; Revenue Tops Last Full Year, but Gross Margin Stays Near 10%
Stocks | 3 days agoDarupakhsh Pharmaceutical Raw Materials (TMVD) Books 18,401 Billion Rials of Six-Month Net Profit, Up 248% and 148% of All of Fiscal 1404
Stocks | yesterdayZahravi Pharmaceutical (DZAH) Lifts Six-Month Net Profit 313% to 6,386 Billion Rials From 1,546 Billion
Stocks | 4 days agoExir Pharmaceutical (EXIR) Six-Month Profit Rises 4.5-Fold to 34,165 Billion Rials, More Than Twice All of Fiscal 1404
Stocks | 17 hours ago
